NEW YORK (AP) — Teva Pharmaceutical is the target of a federal bribery investigation.
The largest generic drug company in the world says the Securities and Exchange Commission is looking into its compliance with the Foreign Corrupt Practice Act, a law that makes it illegal for people or companies to make payments to officials of foreign governments in order to get or keep business. Teva says the SEC subpoenaed documents related to its business in Latin America.
The Israeli company disclosed the inquiry in a form filed with the Securities and Exchange Commission Thursday. Teva says the investigation is in its early stages, and added that it is conducting its own voluntary investigation.
Teva Pharmaceutical Industries Ltd. also sells Copaxone, the biggest-selling multiple sclerosis medication.
What's On TonightFull Schedule